Havrix 720 Junior/Havrix 1440 Adult Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

HAV vaccine (inactivated, adsorbed)

Indications/Uses

Active immunisation against HAV infection in subjects at risk of exposure to HAV.

Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Dosage/Direction for Use

IM Adult ≥19 yr Primary immunisation: Single dose of Havrix 1440 Adult (1 mL susp). Childn & adolescent 1-18 yr Primary immunisation: Single dose of Havrix 720 Junior (0.5 mL susp). Booster: Recommended between 6 & 12 mth after a single dose of Havrix 1440 Adult or Havrix 720 Junior.

Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Overdosage

View Havrix 720 Junior/Havrix 1440 Adult overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Special Precautions

Anaphylactic event following vaccination. Do not administer intravascularly, subcutaneously or intradermally. Do not administer in gluteal region. Administer w/ caution to subjects w/ thrombocytopenia or bleeding disorder. Postpone vaccination in case of acute severe febrile illness. Patients w/ impaired immune system or those on haemodialysis may require additional doses. Pregnancy & lactation.

Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Use In Pregnancy & Lactation

Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Adverse Reactions

Irritability; headache; inj site pain & redness, fatigue. Appetite loss; drowsiness; GI symptoms (eg, diarrhoea, nausea, vomiting); malaise, fever (≥37.5°C), inj site reaction (eg, swelling or induration).

Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Drug Interactions

Administer w/ different syringes & needles at different inj sites when concomitant administration of other vaccines or Ig is considered necessary.

Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Havrix 720 Junior/Havrix 1440 Adult detailed prescribing information

Storage

View Havrix 720 Junior/Havrix 1440 Adult storage conditions for details to ensure optimal shelf-life.

Description

View Havrix 720 Junior/Havrix 1440 Adult description for details of the chemical structure and excipients (inactive components).

Action

View Havrix 720 Junior/Havrix 1440 Adult mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BC02 - hepatitis A, inactivated, whole virus ; Belongs to the class of hepatitis viral vaccines.

Regulatory Classification

P₁S₁S₃

Presentation/Packing

Form

Havrix 1440 Adult vaccine inj 1440 ELISA u/mL

Packing/Price

1's

Form

Havrix 720 Junior vaccine inj 720 ELISA u/0.5 mL

Packing/Price

1's

Havrix 720 Junior/Havrix 1440 Adult

hepatitis a vaccine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig

Agencia Lei Va Hong